ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Vitamin D supplementation could ease IBS symptoms

Increase Your Magnesium Intake

Top Tips to Boost Your Immunity

11 Amazing Health Benefits of Using Baking Soda

Nicotinamide riboside shows promise for treatment of Alzheimer’s disease

Exercise, calcium, vitamin D, and other factors linked with fewer injurious falls

Vitamin D3 Is a Powerhouse for Your Heart

Rhodiola — A Powerful Adaptogen That Boosts Vitality and Performance, Eases Depression and Combats B...

Curcumin Supplementation May Impart Long-Term Cognitive Benefits

Vitamin D deficiency during pregnancy can program obesity in children

 
Print Page
Email Article

Abstract: Efficacy and Safety of a Tramadol/Acetaminophen Combination (Ultracet™) in the Management of Fibromyalgia Related Pain: A Multicenter, Outpatient, Randomized, Double-Blind, Placebo-Controlled Study

  [ 46 votes ]   [ Discuss This Article ]
By Robert Bennett, Mark Kamin, Norman Rosenthal, Rezaul Karim • www.ProHealth.com • November 19, 2001




Objective: To evaluate the efficacy and safety of a new combination analgesic tablet, tramadol/acetaminophen (APAP), for the treatment of pain in fibromyalgia (FM) patients. It is hypothesized that both tramadol and acetaminophen influence spinal inhibitory nociceptive pathways, suggesting that this combination is a promising therapy for central pain states.

Methods: This was a 91 day, multi-center outpatient study comparing the efficacy of tramadol and APAP (37.5 mg/325 mg) tablets to placebo in the management of FM pain. All subjects fulfilled the 1990 ACR classification criteria for FM and had no other significant pain condition. The study employed a parallel, randomized, double-blind, placebo-controlled design. Following an analgesic washout of up to 3 weeks, patients were randomly assigned to either tramadol/APAP or placebo and titrated by 1 tablet every 3 days to a total of 4 tablets/day on Day 10. Thereafter, dose was adjusted as needed to a maximum of 8 tablets/day. The primary outcome variable was time to discontinuation due to insufficient pain relief (Kaplan-Meier analysis). Secondary measures were final pain visual analog (PVA) scores, final pain relief scores, tender-point scores, and fibromyalgia impact questionnaire (FIQ) scores.

Results: A total of 313 patients (94% female, mean age 50) were randomized to tramadol/APAP (n = 156) or placebo (n = 157). Kaplan-Meier estimates of cumulative discontinuation rates due to insufficient pain relief were consistently lower in the tramadol/APAP group (P < .001). Final estimates of cumulative discontinuation rates were 28.1% for tramadol/APAP and 50.8% for placebo (P < .001). Tramadol/APAP patients had significantly better final PVA scores (P <.001), final pain relief scores (P < .001), total tender points scores (P = .040), and total FIQ scores (P = .008). Adverse event discontinuation occurred in 18.6% of tramadol/APAP and 11.5% of placebo patients. The most common adverse events in the tramadol/APAP group were nausea, headache, and pruritis. The average dose of tramadol/APAP was 4.0 tablets/day.

Conclusion: A combination tablet of tramadol and acetaminophen was effective and well tolerated for the treatment of FM related pain without any serious side effects.

Disclosure: The investigators at the 27 participating sites were financially reimbursed by Ortho-McNeill Pharmaceutical, Inc. for conducting this study.

Keywords: Fibromyalgia; Tramadol/Acetaminophen (APAP); efficacy and safety


NOTE: Warnings about seizure risk associated with Tramadol (Ultram) are posted on the FDA web site:

Tramadol HCL Tablets 50 Mg Scored
Proposed Package Insert

WARNINGS
Seizure Risk

Seizures have been reported in patients receiving ULTRAM
within the recommended dosage range. Spontaneous post-
marketing reports indicate that seizure risk is increased with
doses of ULTRAM above the recommended range. Concomitant
use of ULTRAM increases the seizure risk in patients taking:

* Selective serotonin reuptake inhibitors (SSRI antidepressants or anorectics),

* Tricyclic antidepressants (TCAs), and other tricyclic
compounds (e.g., cyclobenzaprine, promethazine, etc.), or Opioids.


Administration of ULTRAM may enhance the seizure risk in
patients taking:

* MAO inhibitors (see also WARNINGS – Use with MAO Inhibitors),

* Neuroleptics, or

* Other drugs that reduce the seizure threshold.

Risk of convulsions may also increase in patients with epilepsy,those with a history of seizures, or in patients with a recognized risk for seizure (such as head trauma, metabolic disorders, alcohol and drug withdrawal, CNS infections). In ULTRAM overdose, naloxone administration may increase the risk of seizure.

Anaphylactoid Reactions

Serious and rarely fatal anaphylactoid reactions have been reported in patients receiving therapy with ULTRAM. These reactions often occur following the first dose. Other reported reactions include pruritus, hives, bronchospasm, and angioedema. Patients with a history of
anaphylactoid reactions to codeine and other opioids may be at

Source: FDA web site (www.fda.gov)




Post a Comment

Featured Products From the ProHealth Store
Ultra ATP+, Double Strength Vitamin D3 Extreme™ Mitochondria Ignite™ with NT Factor®


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Help for Soreness and Swelling: What Do Silkworms Have to Do With It? Help for Soreness and Swelling: What Do Silkworms Have to Do With It?
Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel Irritable Bowel Syndrome: Unlocking the Secrets of Peppermint, Acacia and Fennel
Vitamin E: Super Antioxidant We Only Thought We Knew Vitamin E: Super Antioxidant We Only Thought We Knew
More Weight Loss than Any Other Discovery in Supplement History More Weight Loss than Any Other Discovery in Supplement History
Strengthen Cell Function with Energy-Boosting Niagen Strengthen Cell Function with Energy-Boosting Niagen

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2018 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map